Katapult Delivers Double-Digit Gross Originations Growth in the Fourth Quarter, Above Outlook
Strong Holiday Season Performance; Momentum Continuing into 2025Establishes 2025 Outlook; Expects Growth to Continue in Q1 2025 PLANO, Texas, March […]
Enlight Wins Israel’s First Ever Land Tender for an Integrated Data Center and Renewable Energy Facility in the Ashalim Region
TEL AVIV, Israel, March 28, 2025 (GLOBE NEWSWIRE) — Enlight Renewable Energy (“Enlight”, “the Company”, NASDAQ: ENLT, TASE: ENLT.TA), a […]
West Red Lake Gold Board of Directors Update
VANCOUVER, British Columbia, March 28, 2025 (GLOBE NEWSWIRE) — West Red Lake Gold Mines Ltd. (“West Red Lake Gold” or […]
Quantum Biopharma’s 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern
TORONTO, March 28, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the […]
TSX News -
Aura Minerals Successfully Starts Ramp-Up at Borborema, On Schedule, Within Budget, and Setting an ESG Benchmark
ROAD TOWN, British Virgin Islands, March 28, 2025 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) […]
Diversified Energy Announces Successful Placement of 4-year Senior Secured Notes
BIRMINGHAM, Ala., March 28, 2025 (GLOBE NEWSWIRE) — Diversified Energy Company PLC (LSE: DEC) (NYSE: DEC) (“Diversified” or the “Company”), […]
2024 Full Year Financial Results
Reykjavík, March 28, 2025 (GLOBE NEWSWIRE) — (“Amaroq” or the “Company“) 2024 Full Year Financial Results 2024 – a pivotal […]
Significant Increase in Nalunaq Mineral Resource Estimate
Reykjavík, March 28, 2025 (GLOBE NEWSWIRE) — (“Amaroq” or the “Company” or the “Corporation”) Significant Increase in Nalunaq Mineral Resource […]
Caledonia Mining Corporation Plc: Change to payment date of Caledonia’s April dividend
The following amendment has been made to the Caledonia approves quarterly dividend announcement released on March 24, 2025 at 07:00 […]
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in […]
